Interleukin 10 (IL-10) Upregulates Functional High Affinity IL-2 Receptors on Normal and Leukemic B Lymphocytes

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1993 Nov 1

PMID 8228801

Citations 40

Authors

A C Fluckiger

P Garrone

I Durand

J P Galizzi

J Banchereau

Affiliations

Soon will be listed here.

Abstract

Interleukin 10 (IL-10) has recently been shown to induce normal human B lymphocytes to proliferate and differentiate into immunoglobulin (Ig)-secreting cells. Herein, we show that IL-10 also promotes DNA synthesis and IgM production by anti-CD40 activated B cell chronic lymphocytic leukemia (B-CLL). Most strikingly, IL-2 and IL-10 were found to synergize to induce the proliferation and differentiation of B-CLL cells. This synergy between IL-2 and IL-10 was also observed with normal B cells which proliferated strongly and secreted large amounts of IgM, IgG, and IgA. The observed synergy is likely to be due to the IL-10-induced increase of high affinity IL-2 receptors on both normal and leukemic B cells. This increase of high affinity receptor is associated to an increase of Tac/CD25 expression that can be detected by flow cytometric analysis. Taken together, these results indicate that IL-10 permits anti-CD40 activated B cells to respond to IL-2 through an induction of high affinity IL-2 receptors. This effect of IL-10 may partly explain how T cells, which activate B cells in a CD40-dependent fashion, induce B cell proliferation and differentiation mostly through IL-2.

Citing Articles

Patients and mice with deficiency in the SNARE protein SYNTAXIN-11 have a secondary B cell defect.

Kogl T, Chang H, Staniek J, Chiang S, Thoulass G, Lao J J Exp Med. 2024; 221(7).

PMID: 38722309 PMC: 11082451. DOI: 10.1084/jem.20221122.

Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets.

Glass M, Glass D, Oliveria J, Mbiribindi B, Esquivel C, Krams S Cell Rep. 2022; 39(3):110728.

PMID: 35443184 PMC: 9107325. DOI: 10.1016/j.celrep.2022.110728.

Distinct modes of action of CD40L and adaptive cytokines IL-2, IL-4/13, IL-10 and IL-21 on rainbow trout IgM B cells.

Abos B, Wang T, Secombes C, Tafalla C Dev Comp Immunol. 2020; 111:103752.

PMID: 32447012 PMC: 7397517. DOI: 10.1016/j.dci.2020.103752.

A Review of the Immunomodulating Components of Maternal Breast Milk and Protection Against Necrotizing Enterocolitis.

Nolan L, Parks O, Good M Nutrients. 2019; 12(1).

PMID: 31861718 PMC: 7019368. DOI: 10.3390/nu12010014.

Function and dysfunction of plasma cells in intestine.

Wang X, Hao G, Wang B, Gao C, Wang Y, Li L Cell Biosci. 2019; 9:26.

PMID: 30911371 PMC: 6417281. DOI: 10.1186/s13578-019-0288-9.

References

Lipsky P . The induction of human B-cell activation, proliferation and differentiation by anti-CD3-stimulated T cells--a model of T cell/B cell collaboration. Res Immunol. 1990; 141(4-5):424-7. DOI: 10.1016/0923-2494(90)90034-v. View

MacNeil I, Suda T, Moore K, Mosmann T, Zlotnik A . IL-10, a novel growth cofactor for mature and immature T cells. J Immunol. 1990; 145(12):4167-73. View

Forman M, Pure E . T-independent and T-dependent B lymphoblasts: helper T cells prime for interleukin 2-induced growth and secretion of immunoglobulins that utilize downstream heavy chains. J Exp Med. 1991; 173(3):687-97. PMC: 2118822. DOI: 10.1084/jem.173.3.687. View

Rousset F, Garcia E, Banchereau J . Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med. 1991; 173(3):705-10. PMC: 2118825. DOI: 10.1084/jem.173.3.705. View

Tomizawa K, Ishizaka A, Kojima K, Nakanishi M, Sakiyama Y, Matsumoto S . Interleukin-4 regulates the interleukin-2 receptors on human peripheral blood B lymphocytes. Clin Exp Immunol. 1991; 83(3):492-6. PMC: 1535312. DOI: 10.1111/j.1365-2249.1991.tb05667.x. View

Chen W, Zlotnik A . IL-10: a novel cytotoxic T cell differentiation factor. J Immunol. 1991; 147(2):528-34. View

Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet J . B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL. Blood. 1991; 78(8):1901-14. View

Butcher R, Cushley W . Flow cytometric studies of IL-4-stimulated expression of the CD25 antigen by quiescent human B lymphocyte subpopulations. Immunology. 1991; 74(3):511-8. PMC: 1384648. View

Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J . Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med. 1992; 175(3):671-82. PMC: 2119142. DOI: 10.1084/jem.175.3.671. View

10.

Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu D . Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992; 89(5):1890-3. PMC: 48559. DOI: 10.1073/pnas.89.5.1890. View

11.

Fanslow W, Anderson D, Grabstein K, Clark E, Cosman D, Armitage R . Soluble forms of CD40 inhibit biologic responses of human B cells. J Immunol. 1992; 149(2):655-60. View

12.

Noelle R, Roy M, Shepherd D, Stamenkovic I, Ledbetter J, Aruffo A . A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A. 1992; 89(14):6550-4. PMC: 49539. DOI: 10.1073/pnas.89.14.6550. View

13.

Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N . Cloning of the gamma chain of the human IL-2 receptor. Science. 1992; 257(5068):379-82. DOI: 10.1126/science.1631559. View

14.

Yssel H, de Waal Malefyt R, Roncarolo M, Abrams J, Lahesmaa R, Spits H . IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol. 1992; 149(7):2378-84. View

15.

Banchereau J, Rousset F . Human B lymphocytes: phenotype, proliferation, and differentiation. Adv Immunol. 1992; 52:125-262. DOI: 10.1016/s0065-2776(08)60876-7. View

16.

Fluckiger A, Rossi J, Bussel A, BRYON P, Banchereau J, Defrance T . Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood. 1992; 80(12):3173-81. View

17.

Del Prete G, De Carli M, Almerigogna F, Giudizi M, Biagiotti R, Romagnani S . Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol. 1993; 150(2):353-60. View

18.

Burdin N, Peronne C, Banchereau J, Rousset F . Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J Exp Med. 1993; 177(2):295-304. PMC: 2190909. DOI: 10.1084/jem.177.2.295. View

19.

Rai K, SAWITSKY A, CRONKITE E, CHANANA A, Levy R, Pasternack B . Clinical staging of chronic lymphocytic leukemia. Blood. 1975; 46(2):219-34. View

20.

Binet J, Leporrier M, Dighiero G, Charron D, dAthis P, Vaugier G . A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer. 1977; 40(2):855-64. DOI: 10.1002/1097-0142(197708)40:2<855::aid-cncr2820400239>3.0.co;2-1. View